title: Repurposing of FDA-approved drugs against cancer - focus on metastasis.
authors.affiliation: The Breast Cancer Now Research Unit, Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.|The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.
authors.forename: Béla
authors.initials: B
authors.lastname: Ozsvári
authors.affiliation: The Breast Cancer Now Research Unit, Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.|The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Lamb
authors.affiliation: The Breast Cancer Now Research Unit, Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.|The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, Manchester, UK.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Lisanti
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D058492:Drug Repositioning; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents
keywords: antibiotics; aspirin; repurposing; tumor metastasis